High Demand for Participation in Pickleball's Big Game on
Feb. 9 in Las Vegas Leads to
Tournament's Expansion to 24 Teams and Signing of New
Sponsors
LAS
VEGAS, Feb. 1, 2024 /PRNewswire/ -- Paradise PB
Events and G.O.A.T. Paddle, the high performance pickleball company
created by and for top players and those who want to compete like
them, today announced the expansion of G.O.A.T. Bowl
I tournament play in Las
Vegas to 24 teams and said that registration remains open
for four additional teams. Individual players or teams can go to
https://www.paradisepb.com/event-details-registration/g-o-a-t-bowl-i to
register online. Players who register individually will be assigned
to the final teams assembled by G.O.A.T. Bowl I's organizers. This
amateur competition is part of a full day of pickleball festivities
set for Friday, Feb. 9, at Life Time
Green Valley.
In addition, G.O.A.T. Bowl I named Oso Pickleball as the
official ball sponsor and added Dunkin' to the line-up of event
supporters. G.O.A.T. Bowl I is produced by Paradise PB
Events and presented by Pacira BioSciences' ZILRETTA®.
Additional event sponsors are G.O.A.T. Paddle, Cousins Maine
Lobster, Sweet Las Vegas,
MoneyBall Tour, G.O.A.T. Pickleball Las Vegas, Vocation Jewelry
Service and PN Medical/The Breather.
"Interest in our inaugural G.O.A.T. Bowl has been over the top
from all parts of the pickleball community," said Ryan Reader, CEO and co-founder of Paradise PB
and G.O.A.T. Paddle. "With the high demand for participation we
increased the draw to 24 teams and look forward to packing the
beautiful Life Time outdoor facility. Players and fans will
appreciate not only the caliber of match play, they will enjoy our
food truck line-up, tailgate party, skills challenge and festival
atmosphere. The opening ceremony is set for 10 a.m. and will feature a kick-off message from
Commissioner Rod Woodson,
participation by the Green Valley High School Gators cheerleaders,
and a National Anthem performance by Carnell "Golden Pipes"
Johnson. We will recognize many sports celebrities on site as well
as introduce our G.O.A.T. Team Elite members, Alexa Schull and Rachael
James, two up-and-comers on the PPA and APP pro tours. This
will be pickleball's big event before professional football's big
game in Las Vegas."
In G.O.A.T. Bowl I, 24 teams of four players will compete in
single-elimination, multi-game rounds. For each round, teams will
put on the court two players each to battle in four back-to-back
doubles games to 21 points, with a win by one point required and
points earned every rally. The team that wins three games wins the
match and advances to the next round. In the event of a tie with
each team winning two games, the teams will play a special 21-point
G.O.A.T. Bowl Tiebreaker.
G.O.A.T. Paddle's USAPA-approved paddles and pickleball gear are
available for purchase online with free shipping. Visit
www.goatpaddle.com to purchase the G.O.A.T. Performance paddle and
other gear, connect with the G.O.A.T. team members and keep up on
the latest developments. Join the G.O.A.T. Paddle community on
social media by following the company on Instagram at
www.instagram.com/goatpaddle, Facebook at
www.facebook.com/goatpaddle, TikTok at www.tiktok.com/@goatpaddle
and Threads at www.threads.net/@goatpaddle. Contact G.O.A.T. Paddle
via email at support@goatpaddle.com.
About Pacira BioSciences
Pacira BioSciences, Inc.
(Nasdaq: PCRX) is committed to providing a non-opioid option to as
many patients as possible to redefine the role of opioids as rescue
therapy only. The company is also developing innovative
interventions to address debilitating conditions involving the
sympathetic nervous system, such as cardiac electrical storm,
chronic pain, and spasticity. Pacira has three commercial-stage
non-opioid treatments: EXPAREL® (bupivacaine liposome injectable
suspension), a long-acting local analgesic currently approved for
infiltration, fascial plane block, and as an interscalene brachial
plexus nerve block for postsurgical pain management; ZILRETTA®
(triamcinolone acetonide extended-release injectable suspension),
an extended-release, intra-articular injection indicated for the
management of osteoarthritis knee pain; and ioveraº®, a novel,
handheld device for delivering immediate, long-acting, drug-free
pain control using precise, controlled doses of cold temperature to
a targeted nerve. To learn more about Pacira, including the
corporate mission to reduce overreliance on opioids, visit
www.pacira.com.
About ZILRETTA®
On Oct. 6, 2017, ZILRETTA (triamcinolone acetonide
extended-release injectable suspension) was approved by the U.S.
Food and Drug Administration as the first and only extended-release
intra-articular therapy for patients confronting osteoarthritis
(OA)-related knee pain. ZILRETTA employs proprietary microsphere
technology combining triamcinolone acetonide – a commonly
administered, short-acting corticosteroid – with a poly
lactic-co-glycolic acid (PLGA) matrix to provide extended pain
relief. The pivotal Phase 3 trial on which the approval of ZILRETTA
was based showed that ZILRETTA significantly reduced OA knee pain
for 12 weeks, with some people experiencing pain relief through
Week 16. Learn more at www.zilretta.com.
Media Contact:
David Schull
(858) 717-2310
371738@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/goat-bowl-i-registration-open-to-4-additional-pickleball-teams-302050920.html
SOURCE G.O.A.T. Paddle